RuiYi Inc. – Asian Scientist Magazine

subscribe

ruiyi inc

Pharma

RuiYi Raises US$15 Million And Expands Leadership Team

Chinese biotechnology company RuiYi, Inc. has raised US$15 million in Series B financing to develop their pipeline of monoclonal antibodies.

Pharma

Anaphore Acquires Shanghai-Based RuiYi For Biologics Drug Discovery Platform

Anaphore Inc. has acquired Shanghai-based RuiYi Inc., a company that develops small molecule drugs targeting G protein coupled receptors.

EDITOR’S PICK

10 Years Of Celebrating Asia’s Researchers

Every year, Asian Scientist Magazine publishes Asian Scientist 100, a carefully curated list of the best and brightest researchers and leaders in SETM in Asia. This year we complete a decade of doing so.
Learning From Environmental Defenders

Drawing on traditional knowledge systems, environmental researchers and policymakers in Asia are working with indigenous communities to design better strategies for environmental conservation.
The Equalizers

Across Asia, people with disabilities are breaking physical and social barriers to STEM fields, opening the way for others.